ValuEngine Lowers Fortress Biotech (FBIO) to Strong Sell


A number of other equities research analysts also recently issued reports on the stock. Zacks Investment Research downgraded shares of Fortress Biotech from a "hold" rating to a "sell" rating in a research note on Tuesday, September 12th.



from Biotech News